The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.
This report provides:
An overview of the global market for antibodies used in research.
Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
Segmentation of the market by geography, product types, research applications, species, and major research area.
Details concerning end user types, purchasing factors, new market trends, and potential growth opportunities that are available.
Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
Analysis of the competitive landscape and key competitor market shares.
SCOPE OF REPORT
This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.